In the literature review, it was found that researchers utilized CA‐125 for diagnosing ovarian cancer, its predicting, evaluating treatment response, assessing ovarian cancer survival, and early detection of recurrence. The gene discussed is MUC16; the disease is ovarian carcinoma.